newsfilter
← Latest News
GlobeNewswire·

Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (NASDAQ:LXEO) a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that